Zhejiang Tailin Life Science Co., Ltd. announced a private placement of common shares for gross proceeds of CNY 40 million on April 18, 2022. The transaction will include participation from returning investor Zhejiang Tailin BioEngineering Co.,Ltd. The transaction has been approved at the fifth meeting of the third board of directors of Zhejiang Tailin BioEngineering Co.,Ltd. Post the closing, the registered capital of the company will increase from CNY 10 million to CNY 50 million.